Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

Blood Cell Cancer Research

Study Title:  A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma (Identifier: NCT01564537)

Study Purpose:  The purpose of this phase 3, randomized, double-blind, multicenter study is to compare Oral MLN9708 plus Lenalidomide and Dexamethasone versus Placebo plus Lenalidomide and Dexamethasone in adult patients with relapsed and/or refractory multiple myeloma. 

Principal Investigator: Cherian Verghese, M.D.

Study Coordinator: Stephanie Smiddy, RN for more information, please contact 419.383.6794.

Last Updated: 11/6/14